AC Immune SA (NAS:ACIU)
$ 3.59 0 (0%) Market Cap: 355.05 Mil Enterprise Value: 241.33 Mil PE Ratio: 0 PB Ratio: 2.18 GF Score: 44/100

AC Immune SA KOL Webinar Transcript

Nov 09, 2023 / 03:00PM GMT
Release Date Price: $2.98 (-0.67%)
Operator

Good morning, and welcome to the AC Immune KOL webinar. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the AC Immune website following the conclusion of the event.

I'd now like to turn the call over to Gary Waanders, Head of Investor Relations and Communications at AC Immune. Please go ahead, Gary.

Gary Waanders
AC Immune SA - Head of IR & Corporate Communications

Thanks, Tara. It's a pleasure to welcome you all to our webinar today on the topic of Abeta PET imaging and its importance as a surrogate marker of clinical efficacy. Before we begin, I'd like to draw your attention to our disclaimer about our forward-looking statements.

And so today, we'll be hearing from our CEO at AC Immune, Andrea Pfeifer, to present an overview of the company's strategy and pipeline, with a focus on our active immunotherapy platform, particularly as it relates to our anti-Abeta candidate, ACI-24.060. Then we will hear from Professor Victor Villemagne of the University of Pittsburgh, an

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot